Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 199 Total
CAN - Canaan Inc ADR - Stock Price Chart
TickerCAN [NASD]
CompanyCanaan Inc ADR
CountrySingapore
IndustryComputer Hardware
Market Cap224.24MEPS (ttm)-2.40
P/E-EPS this Y94.48%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.06EPS next 5Y-
P/B0.64EPS Q/Q-109.77%
Dividend-Sales Q/Q-10.90%
Insider Own-Inst Own27.69%
Insider Trans-Inst Trans-8.15%
Short Float17.81%EarningsMay 17/b
Analyst Recom1.00Target Price3.00
Avg Volume14.12M52W Range0.75 - 3.50
Canaan, Inc. is a holding company, which engages in developing and selling Bitcoin mining machines and related services. It focuses on the development of green mining. The company was founded by Jia Xuan Li, Xiang Fu Liu and Nan Geng Zhang in 2013 and is headquartered in Singapore.
CTCX - Carmell Corp - Stock Price Chart
TickerCTCX [NASD]
CompanyCarmell Corp
CountryUSA
IndustryBiotechnology
Market Cap42.64MEPS (ttm)-0.56
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S11.43EPS next 5Y-
P/B-EPS Q/Q-1833.06%
Dividend-Sales Q/Q-
Insider Own36.42%Inst Own17.57%
Insider Trans0.84%Inst Trans4.83%
Short Float0.21%Earnings-
Analyst Recom-Target Price-
Avg Volume7.46K52W Range1.70 - 13.31
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sturgeon Patrick ADirectorDec 15 '23Buy3.947392,9086,727Dec 18 05:11 PM
Gregory KathrynDirectorDec 15 '23Buy3.947392,9086,727Dec 18 05:10 PM
Anderson David WDirectorDec 15 '23Buy3.947392,9086,727Dec 18 05:10 PM
Spenlehauer GillesDirectorDec 15 '23Buy3.945912,3265,381Dec 18 05:13 PM
Frisch Scott M.DirectorDec 15 '23Buy3.945912,3265,381Dec 18 05:12 PM
IXHL - Incannex Healthcare Inc - Stock Price Chart
TickerIXHL [NASD]
CompanyIncannex Healthcare Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap39.67MEPS (ttm)-0.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.94%
P/S-EPS next 5Y-
P/B2.81EPS Q/Q-294.91%
Dividend-Sales Q/Q-
Insider Own27.69%Inst Own1.31%
Insider Trans0.00%Inst Trans-
Short Float0.48%Earnings-
Analyst Recom-Target Price-
Avg Volume319.72K52W Range1.96 - 12.68
Incannex Healthcare, Inc. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It operates through the following segments: Psychedelic Products, Cannabinoid Products, and Corporate. The Psychedelic Products segment is involved in the use of psychedelic medicine and therapies for the treatment of mental health disorders. The Cannabinoid Products segment focuses on the use of medicinal cannabinoid products. The Corporate segment includes management of the organization, capital management, and management of resources. The company was founded on April 27, 2001 and is headquartered in New York, NY.
ALT - Altimmune Inc - Stock Price Chart
TickerALT [NASD, RUT]
CompanyAltimmune Inc
CountryUSA
IndustryBiotechnology
Market Cap567.91MEPS (ttm)-1.59
P/E-EPS this Y7.32%
Forward P/E-EPS next Y-1.28%
PEG-EPS past 5Y35.74%
P/S1385.14EPS next 5Y-
P/B3.28EPS Q/Q13.98%
Dividend-Sales Q/Q-76.19%
Insider Own6.68%Inst Own62.69%
Insider Trans0.00%Inst Trans10.67%
Short Float33.71%EarningsMay 09/b
Analyst Recom1.50Target Price20.57
Avg Volume4.34M52W Range2.09 - 14.84
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts M ScotChief Scientific OfficerFeb 02 '24Option Exercise0.007,775044,990Feb 05 06:02 PM
Harris Matthew ScottChief Medical OfficerFeb 02 '24Option Exercise0.007,775055,965Feb 05 06:01 PM
Garg Vipin KPresident and CEOFeb 02 '24Option Exercise0.0018,9500300,404Feb 05 06:00 PM
Harris Matthew ScottChief Medical OfficerFeb 01 '24Option Exercise0.006,166049,991Feb 05 06:01 PM
Roberts M ScotChief Scientific OfficerFeb 01 '24Option Exercise0.006,166039,016Feb 05 06:02 PM
MORF - Morphic Holding Inc - Stock Price Chart
TickerMORF [NASD, RUT]
CompanyMorphic Holding Inc
CountryUSA
IndustryBiotechnology
Market Cap1.46BEPS (ttm)-3.38
P/E-EPS this Y-9.58%
Forward P/E-EPS next Y-9.68%
PEG-EPS past 5Y-35.64%
P/S-EPS next 5Y-
P/B2.21EPS Q/Q-0.54%
Dividend-Sales Q/Q-100.00%
Insider Own22.78%Inst Own88.51%
Insider Trans-0.31%Inst Trans-1.45%
Short Float16.59%EarningsApr 25/b
Analyst Recom1.40Target Price56.00
Avg Volume446.21K52W Range19.34 - 63.08
Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rogers BrucePRESIDENTMar 27 '24Option Exercise4.327,40031,932149,883Mar 28 07:00 PM
Tipirneni Praveen P.CEOJan 16 '24Sale27.4913,923382,75342,013Jan 17 07:04 PM
Rogers BrucePresidentJan 16 '24Sale27.496,314173,576142,036Jan 17 07:02 PM
SCHEGERIN MARCCFO and COOJan 16 '24Sale27.496,041166,07137,460Jan 17 07:03 PM
Farrell Robert E JrSVP Finance and CAOJan 16 '24Sale27.495,089139,90034,992Jan 17 07:01 PM
NOTV - Inotiv Inc - Stock Price Chart
TickerNOTV [NASD]
CompanyInotiv Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap50.12MEPS (ttm)-2.76
P/E-EPS this Y31.54%
Forward P/E-EPS next Y38.84%
PEG-EPS past 5Y-184.24%
P/S0.09EPS next 5Y-
P/B0.24EPS Q/Q-378.36%
Dividend-Sales Q/Q-21.41%
Insider Own10.83%Inst Own25.40%
Insider Trans2.20%Inst Trans-9.15%
Short Float4.89%EarningsMay 15/a
Analyst Recom2.33Target Price4.67
Avg Volume572.19K52W Range1.61 - 11.42
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beattie John GregoryChief Operating OfficerDec 14 '23Buy3.1247,966149,836111,761Dec 15 05:33 PM
Garrett MichaelChief Commercial OfficerDec 14 '23Buy2.835,00014,14516,467Dec 15 05:33 PM
GRWG - GrowGeneration Corp - Stock Price Chart
TickerGRWG [NASD, RUT]
CompanyGrowGeneration Corp
CountryUSA
IndustrySpecialty Retail
Market Cap158.45MEPS (ttm)-0.80
P/E-EPS this Y53.11%
Forward P/E-EPS next Y35.36%
PEG-EPS past 5Y-28.61%
P/S0.73EPS next 5Y20.00%
P/B0.97EPS Q/Q-42.99%
Dividend-Sales Q/Q-15.73%
Insider Own7.08%Inst Own37.37%
Insider Trans0.00%Inst Trans-1.90%
Short Float7.10%EarningsMay 08/a
Analyst Recom2.14Target Price3.82
Avg Volume1.40M52W Range1.77 - 4.23
GrowGeneration Corp. engages in the development, marketing, retail, and distribution of hydroponic products and services. It operates through the following segments: Cultivating and Gardening, Storage Solutions, and Corporate. The Cultivating and Gardening segment includes hydroponic and organic gardening business. The Storage Solutions segment involves benching and racking. The company was founded by Darren Lampert and Michael S. Salaman on March 6, 2014 and is headquartered in Greenwood Village, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salaman MichaelPresidentNov 15 '23Buy2.35302,766710,1381,240,075Nov 16 04:29 PM
Lampert DarrenCEONov 15 '23Buy2.3621,00049,6381,333,120Nov 15 06:37 PM
Lampert DarrenCEONov 14 '23Buy2.11175,000368,8301,312,120Nov 15 06:37 PM
Salaman MichaelPresidentNov 14 '23Buy2.15127,234272,968937,309Nov 16 04:29 PM
Lampert DarrenCEONov 13 '23Buy1.92300,000575,4001,137,120Nov 15 06:37 PM
SYRA - Syra Health Corp - Stock Price Chart
TickerSYRA [NASD]
CompanySyra Health Corp
CountryUSA
IndustryMedical Care Facilities
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-EarningsMay 09/b
Analyst Recom-Target Price-
Avg Volume500.29K52W Range0.81 - 8.37
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Allam SandeepPresident and ChairDec 14 '23Buy1.312943853,730Dec 26 04:15 PM
Syed Feroz10% OwnerDec 14 '23Buy1.421752481,825Dec 26 04:15 PM
Allam SandeepPresident and ChairDec 13 '23Buy1.406479063,436Dec 26 04:15 PM
Syed Feroz10% OwnerDec 13 '23Buy1.362002721,650Dec 26 04:15 PM
Allam SandeepPresident and ChairDec 12 '23Buy1.404255952,789Dec 26 04:15 PM
NVAX - Novavax, Inc. - Stock Price Chart
TickerNVAX [NASD, RUT]
CompanyNovavax, Inc.
CountryUSA
IndustryBiotechnology
Market Cap1.83BEPS (ttm)-3.18
P/E-EPS this Y101.17%
Forward P/E-EPS next Y-968.43%
PEG-EPS past 5Y11.55%
P/S1.83EPS next 5Y37.90%
P/B-EPS Q/Q69.08%
Dividend-Sales Q/Q15.94%
Insider Own4.98%Inst Own56.59%
Insider Trans-0.67%Inst Trans3.20%
Short Float33.68%EarningsMay 10/b
Analyst Recom2.00Target Price18.00
Avg Volume12.77M52W Range3.53 - 15.00
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
BTOG - Bit Origin Ltd - Stock Price Chart
TickerBTOG [NASD]
CompanyBit Origin Ltd
CountryUSA
IndustryCapital Markets
Market Cap19.47MEPS (ttm)-10.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.75EPS next 5Y-
P/B2.20EPS Q/Q-62.83%
Dividend-Sales Q/Q40.16%
Insider Own11.31%Inst Own0.03%
Insider Trans0.00%Inst Trans-
Short Float5.22%Earnings-
Analyst Recom-Target Price-
Avg Volume403.34K52W Range1.25 - 9.71
Bit Origin Ltd. operates as an emerging growth company which engages in crypto mining business. The firm also actively deploys blockchain technologies, alongside diversified expansion strategies. It has operations in the United States, Canada, and China. The company was founded on January 23, 2018 and is headquartered in New York, NY.
123456789101120